40. 高安動脈炎 Takayasu arteritis Clinical trials / Disease details


臨床試験数 : 24 薬物数 : 40 - (DrugBank : 18) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 110

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04299971
(ClinicalTrials.gov)
March 1, 20205/3/2020Efficiency of Methotrexate and Tofacitinib in Mild and Moderate PatientsRandomized Open-label Study in Mild and Moderate Patients With Takayasu Arteritis Between Methotrexate and Tofacitinib Based on the ECTA Cohort.Takayasu Arteritis;Methotrexate;Inhibition;TreatmentDrug: Methotrexate Tablets;Drug: Tofacitinib tabletShanghai Zhongshan HospitalNULLRecruiting14 Years100 YearsAll130Phase 4China
2NCT03096275
(ClinicalTrials.gov)
March 16, 201713/3/2017Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's ArteritisComparison of the Efficacy of Mycophenolate Mofetil Combined With Methotrexate and Cyclophosphamide for the Treatment of Takayasu's ArteritisTakayasu ArteritisDrug: MMF;Drug: CYC;Drug: Glucocorticoids;Drug: MTX;Drug: AZAChinese SLE Treatment And Research GroupPeking Union Medical College HospitalActive, not recruiting18 YearsN/AAll138Phase 3China